Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Prognosis"" wg kryterium: Temat


Tytuł :
Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis.
Autorzy :
Yang X; Department of Tumor Biological Treatment.; Jiangsu Engineering Research Center for Tumor Immunotherapy.
Song X; Department of Tumor Biological Treatment.
Zhang L; Department of Tumor Biological Treatment.; Jiangsu Engineering Research Center for Tumor Immunotherapy.
Wu C; Department of Tumor Biological Treatment.; Jiangsu Engineering Research Center for Tumor Immunotherapy.; Institute of Cell Therapy, The Third Affiliated Hospital of Soochow University, Jiangsu Changzhou 213003, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Mar; Vol. 99 (10), pp. e19362.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Prognosis*
C-Reactive Protein/*analysis
Serum Albumin/*analysis
Stomach Neoplasms/*blood
Humans ; Proportional Hazards Models ; ROC Curve
Czasopismo naukowe
Tytuł :
The association between the methylation frequency of BRCA1/2 gene promoter and occurrence and prognosis of breast carcinoma: A meta-analysis.
Autorzy :
Li S; Clinical Laboratory, Chongqing Health Center for Women and Children.
He Y; Clinical Laboratory, Yongchuan Hospital of Chongqing Medical University, Chongqing.
Li C; Clinical Laboratory, Chongqing Health Center for Women and Children.
Liu X; Clinical Laboratory, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
Shen Y; Clinical Laboratory, Chongqing Health Center for Women and Children.
Wu Y; Clinical Laboratory, Yongchuan Hospital of Chongqing Medical University, Chongqing.
Bai N; Clinical Laboratory, Yongchuan Hospital of Chongqing Medical University, Chongqing.
Li Q; Clinical Laboratory, Chongqing Health Center for Women and Children.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Mar; Vol. 99 (10), pp. e19345.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Prognosis*
BRCA1 Protein/*analysis
BRCA2 Protein/*analysis
Breast Neoplasms/*genetics
DNA Methylation/*genetics
BRCA1 Protein/blood ; BRCA2 Protein/blood ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/blood ; Breast Neoplasms/physiopathology ; Female ; Humans ; Middle Aged ; Proportional Hazards Models
Czasopismo naukowe
Tytuł :
[Prognostic model of small sample critical diseases based on transfer learning].
Autorzy :
Xia J; College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou 310027, P.R.China.
Pan S; College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou 310027, P.R.China.
Yan M; Department of ICU, Zhejiang Hospital, Hangzhou 310013, P.R.China.
Cai G; Department of ICU, Zhejiang Hospital, Hangzhou 310013, P.R.China.
Yan J; Department of ICU, Zhejiang Hospital, Hangzhou 310013, P.R.China.
Ning G; College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou 310027, P.R.China.
Pokaż więcej
Źródło :
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi [Sheng Wu Yi Xue Gong Cheng Xue Za Zhi] 2020 Feb 25; Vol. 37 (1), pp. 1-9.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Sichuan Sheng sheng wu yi xue gong cheng xue hui Country of Publication: China NLM ID: 9426398 Publication Model: Print Cited Medium: Print ISSN: 1001-5515 (Print) Linking ISSN: 10015515 NLM ISO Abbreviation: Sheng Wu Yi Xue Gong Cheng Xue Za Zhi Subsets: MEDLINE
MeSH Terms :
Algorithms*
Disease*
Machine Learning*
Prognosis*
Humans ; Models, Theoretical
Czasopismo naukowe
Tytuł :
High C-reactive protein to albumin ratio and the short-term survival prognosis within 30 days in terminal cancer patients receiving palliative care in a hospital setting: A retrospective analysis.
Autorzy :
Ju SY; Department of Family Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul.
Ma SJ; Department of Family Medicine, College of Medicine, Chosun University, Gwangju, Republic of Korea.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Feb; Vol. 99 (9), pp. e19350.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Prognosis*
C-Reactive Protein/*classification
Neoplasms/*complications
Serum Albumin, Human/*classification
Adult ; Aged ; C-Reactive Protein/analysis ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/blood ; Palliative Care/methods ; Proportional Hazards Models ; Retrospective Studies ; Serum Albumin, Human/analysis
Czasopismo naukowe
Tytuł :
Comprehensive prognostic scoring systems could improve the prognosis of adult acute myeloid leukemia patients.
Autorzy :
Zhou F; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Zhou F; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Du M; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Liu L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Guo T; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Xia L; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Jin R; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Mei H; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. .
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2019 Nov; Vol. 110 (5), pp. 575-583. Date of Electronic Publication: 2019 Aug 22.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int. J. Hematol. Subsets: MEDLINE
MeSH Terms :
Prognosis*
Leukemia, Myeloid, Acute/*diagnosis
Risk Assessment/*methods
Adolescent ; Adult ; Disease-Free Survival ; Female ; Humans ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Remission Induction ; Risk Assessment/standards ; Survival Analysis
Czasopismo naukowe
Tytuł :
Evaluating risk prediction models for adults with heart failure: A systematic literature review.
Autorzy :
Di Tanna GL; Statistics Division, The George Institute for Global Health, Sydney, Australia.
Wirtz H; Global Health Economics, Amgen Inc., Thousand Oaks, CA, United States America.
Burrows KL; Curo Payer Evidence, Envision Pharma Group, Horsham, United Kingdom.
Globe G; Global Health Economics, Amgen Inc., Thousand Oaks, CA, United States America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Jan 15; Vol. 15 (1), pp. e0224135. Date of Electronic Publication: 2020 Jan 15 (Print Publication: 2020).
Typ publikacji :
Journal Article; Systematic Review
Journal Info :
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS ONE Subsets: MEDLINE
MeSH Terms :
Health Personnel*
Prognosis*
Diabetes Mellitus/*epidemiology
Heart Failure/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Atrial Natriuretic Factor/genetics ; Blood Pressure ; Diabetes Mellitus/physiopathology ; Female ; Heart Failure/genetics ; Heart Failure/physiopathology ; Hospitalization ; Humans ; Male ; Middle Aged ; Risk Assessment ; Risk Factors ; Stroke Volume/genetics ; Stroke Volume/physiology ; Ventricular Function, Left/physiology
Czasopismo naukowe
Tytuł :
Circular RNA circHIPK3 serves as a prognostic marker to promote chronic myeloid leukemia progression.
Autorzy :
Feng XQ; Department of Hematology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Nie SM; Department of Neurology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Huang JX; Department of Hematology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Li TL; Department of Hematology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Zhou JJ; Department of Hematology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Wang W; Department of Hematology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Zhuang LK; Institute of Transplantation Science, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Meng FJ; Department of Hematology, Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Pokaż więcej
Źródło :
Neoplasma [Neoplasma] 2020 Jan; Vol. 67 (1), pp. 171-177. Date of Electronic Publication: 2019 Jun 28.
Typ publikacji :
Journal Article
Journal Info :
Publisher: AE Press Country of Publication: Slovakia NLM ID: 0377266 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0028-2685 (Print) Linking ISSN: 00282685 NLM ISO Abbreviation: Neoplasma Subsets: MEDLINE
MeSH Terms :
Prognosis*
Biomarkers, Tumor/*genetics
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*diagnosis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics
RNA, Circular/*blood
Biomarkers, Tumor/blood ; Disease Progression ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology ; Leukocytes, Mononuclear/metabolism
Czasopismo naukowe
Tytuł :
Health outcome prediction using multiple perturbations.
Autorzy :
Lee WC
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Jan; Vol. 99 (2), pp. e18664.
Typ publikacji :
Journal Article; Observational Study
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Algorithms*
Prognosis*
Humans
Czasopismo naukowe
Tytuł :
A prognostic biomarker of corneal repair.
Autorzy :
Mehta JS; Singapore National Eye Centre, Singapore, Singapore. .; Singapore Eye Research Institute, Singapore, Singapore. .; Duke-NUS Graduate Medical School, Singapore, Singapore. .; School of Materials Science and Engineering, Nanyang Technological University, Singapore, Singapore. .
Kocaba V; Singapore National Eye Centre, Singapore, Singapore.; Singapore Eye Research Institute, Singapore, Singapore.; Duke-NUS Graduate Medical School, Singapore, Singapore.
Peh GS; Singapore National Eye Centre, Singapore, Singapore.; Singapore Eye Research Institute, Singapore, Singapore.; Duke-NUS Graduate Medical School, Singapore, Singapore.
Pokaż więcej
Źródło :
Nature biomedical engineering [Nat Biomed Eng] 2019 Dec; Vol. 3 (12), pp. 945-946.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE
MeSH Terms :
Biomarkers*
Prognosis*
Cornea/*pathology
Cornea/diagnostic imaging ; Cornea/surgery ; Corneal Transplantation ; Endothelial Cells ; Humans ; Tissue Engineering
Czasopismo naukowe
Tytuł :
Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
Autorzy :
Li Z; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Shijiazhuang, 050035, China. .
Shen D; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Shijiazhuang, 050035, China.
Zhang J; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Shijiazhuang, 050035, China.
Zhang J; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Shijiazhuang, 050035, China.
Yang F; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Shijiazhuang, 050035, China.
Kong D; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Shijiazhuang, 050035, China.
Kong J; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Shijiazhuang, 050035, China.
Zhang A; Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, 169 Tianshan Street, Shijiazhuang, 050035, China.
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2019 Nov 14; Vol. 19 (1), pp. 1104. Date of Electronic Publication: 2019 Nov 14.
Typ publikacji :
Journal Article
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
MeSH Terms :
Cranial Irradiation*
Prognosis*
Brain Neoplasms/*radiotherapy
Carcinoma, Non-Small-Cell Lung/*radiotherapy
Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/epidemiology ; Brain Neoplasms/pathology ; Brain Neoplasms/secondary ; Carcinoma, Non-Small-Cell Lung/epidemiology ; Carcinoma, Non-Small-Cell Lung/pathology ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
Autorzy :
Lee SY; Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Jung W; Department of Pathology, Na-eun Hospital, Incheon, Korea.
Lee J; Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Kim A; Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Kim HK; Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
Kim BH; Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea. .
Pokaż więcej
Źródło :
Histology and histopathology [Histol Histopathol] 2019 Nov; Vol. 34 (11), pp. 1279-1288. Date of Electronic Publication: 2019 May 08.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Histology and Histopathology Country of Publication: Spain NLM ID: 8609357 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-5848 (Electronic) Linking ISSN: 02133911 NLM ISO Abbreviation: Histol. Histopathol. Subsets: MEDLINE
MeSH Terms :
Carcinoma, Hepatocellular*/metabolism
Carcinoma, Hepatocellular*/mortality
Carcinoma, Hepatocellular*/pathology
Liver Neoplasms*/metabolism
Liver Neoplasms*/mortality
Liver Neoplasms*/pathology
Prognosis*
Biomarkers, Tumor/*metabolism
Chromosomal Proteins, Non-Histone/*metabolism
Oncogene Proteins/*metabolism
Poly-ADP-Ribose Binding Proteins/*metabolism
Adult ; Aged ; Cadherins/metabolism ; Cyclin D1/metabolism ; Cyclin-Dependent Kinase 4/metabolism ; Disease-Free Survival ; Female ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Proto-Oncogene Proteins/metabolism ; Survival Rate ; Wnt Proteins/metabolism ; beta Catenin/metabolism
Czasopismo naukowe
Tytuł :
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy.
Autorzy :
Kim TG; Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea.; Department of Radiation Oncology, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
Park W; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim H; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Choi DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Park HC; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim SH; Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cho YB; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Yun SH; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kim HC; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee WY; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee J; Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Kang KM; Department of Radiation Oncology, Gyeongsang National University College of Medicine, Jinju, Republic of Korea.
Pokaż więcej
Źródło :
Tumori [Tumori] 2019 Oct; Vol. 105 (5), pp. 434-440. Date of Electronic Publication: 2018 Aug 17.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-2529 (Electronic) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE
MeSH Terms :
Prognosis*
Rectal Neoplasms/*blood
Rectal Neoplasms/*drug therapy
Rectal Neoplasms/*radiotherapy
Adult ; Aged ; Chemoradiotherapy/adverse effects ; Female ; Humans ; Lymphocytes/drug effects ; Lymphocytes/radiation effects ; Male ; Middle Aged ; Neoadjuvant Therapy/adverse effects ; Neutrophils/drug effects ; Neutrophils/radiation effects ; Rectal Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Identification and potential mechanisms of a 4-lncRNA signature that predicts prognosis in patients with laryngeal cancer.
Autorzy :
Zhang G; Department of Head and Neck Oncology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou Province, People's Republic of China. .
Fan E; Zunyi Medical University, Zunyi, 563000, Guizhou Province, People's Republic of China.
Zhong Q; Zunyi Medical University, Zunyi, 563000, Guizhou Province, People's Republic of China.
Feng G; Department of Head and Neck Oncology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou Province, People's Republic of China.
Shuai Y; Zunyi Medical University, Zunyi, 563000, Guizhou Province, People's Republic of China.
Wu M; Zunyi Medical University, Zunyi, 563000, Guizhou Province, People's Republic of China.
Chen Q; Zunyi Medical University, Zunyi, 563000, Guizhou Province, People's Republic of China.
Gou X; Department of Head and Neck Oncology, Affiliated Hospital of Zunyi Medical University, Zunyi, 563000, Guizhou Province, People's Republic of China. .
Pokaż więcej
Źródło :
Human genomics [Hum Genomics] 2019 Aug 15; Vol. 13 (1), pp. 36. Date of Electronic Publication: 2019 Aug 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 101202210 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-7364 (Electronic) Linking ISSN: 14739542 NLM ISO Abbreviation: Hum. Genomics Subsets: MEDLINE
MeSH Terms :
Prognosis*
Biomarkers, Tumor/*genetics
Laryngeal Neoplasms/*genetics
RNA, Long Noncoding/*genetics
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Laryngeal Neoplasms/pathology ; Male ; Middle Aged ; Proportional Hazards Models ; Risk Factors
Czasopismo naukowe
Tytuł :
Sarcopenia Is Associated With Impaired Overall Survival After Gastrectomy for Elderly Gastric Cancer.
Autorzy :
Yamamoto K; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan .; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Hirao M; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Nishikawa K; Department of Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Omori T; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Yanagimoto Y; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Shinno N; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Sugimura K; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Miyata H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Wada H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Takahashi H; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Yasui M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Ohue M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Yano M; Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Fujitani K; Department of Surgery, Osaka General Medical Center, Osaka, Japan.
Tsujinaka T; Department of Surgery, Kaizuka City Hospital, Osaka, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2019 Aug; Vol. 39 (8), pp. 4297-4303.
Typ publikacji :
Journal Article
Journal Info :
Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res. Subsets: MEDLINE
MeSH Terms :
Gastrectomy*
Prognosis*
Sarcopenia/*pathology
Stomach Neoplasms/*surgery
Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Neoplasm Recurrence, Local/pathology ; Postoperative Complications/pathology ; Risk Factors ; Sarcopenia/etiology ; Stomach Neoplasms/complications ; Stomach Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases.
Autorzy :
Rades D; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany .
Hansen HC; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.
Dziggel L; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.
Janssen S; Department of Radiation Oncology, University of Lübeck, Lübeck, Germany.; Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany.
Schild SE; Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2019 Aug; Vol. 39 (8), pp. 4273-4277.
Typ publikacji :
Journal Article
Journal Info :
Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res. Subsets: MEDLINE
MeSH Terms :
Prognosis*
Brain Neoplasms/*radiotherapy
Neoplasms/*radiotherapy
Aged ; Brain Neoplasms/pathology ; Brain Neoplasms/secondary ; Cranial Irradiation/adverse effects ; Female ; Humans ; Karnofsky Performance Status ; Male ; Middle Aged ; Neoplasm Staging ; Neoplasms/classification ; Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Systematic review and REMARK scoring of renal cell carcinoma prognostic circulating biomarker manuscripts.
Autorzy :
Iafolla MAJ; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Picardo S; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Aung K; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.; Livestrong Cancer Institute and Dell Medical School, University of Texas at Austin, Austin, Texas, United States of America.
Hansen AR; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2019 Oct 22; Vol. 14 (10), pp. e0222359. Date of Electronic Publication: 2019 Oct 22 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Systematic Review
Journal Info :
Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS ONE Subsets: MEDLINE
MeSH Terms :
Prognosis*
Biomarkers, Tumor/*blood
Carcinoma, Renal Cell/*blood
DNA Methylation/*genetics
Carcinoma, Renal Cell/epidemiology ; Carcinoma, Renal Cell/genetics ; Humans
Czasopismo naukowe
Tytuł :
Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing.
Autorzy :
Lai CH; Department of Clinical Laboratory, The Third Affiliated Hospital of Guangxi Medical University/Nanning Second People's Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
Liang XZ; Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, China.
Liang XY; Department of Clinical Laboratory, The Third Affiliated Hospital of Guangxi Medical University/Nanning Second People's Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
Ma SJ; Department of Clinical Laboratory, The Third Affiliated Hospital of Guangxi Medical University/Nanning Second People's Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
Li JG; Department of Clinical Laboratory, The Third Affiliated Hospital of Guangxi Medical University/Nanning Second People's Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
Shi MF; Department of Clinical Laboratory, The Third Affiliated Hospital of Guangxi Medical University/Nanning Second People's Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
Zhu X; Department of Clinical Laboratory, The Third Affiliated Hospital of Guangxi Medical University/Nanning Second People's Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
Lan HH; Department of Clinical Laboratory, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, China.
Zeng JH; Department of Clinical Laboratory, The Third Affiliated Hospital of Guangxi Medical University/Nanning Second People's Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
Pokaż więcej
Źródło :
BioMed research international [Biomed Res Int] 2019 Oct 15; Vol. 2019, pp. 8016120. Date of Electronic Publication: 2019 Oct 15 (Print Publication: 2019).
Typ publikacji :
Journal Article
Journal Info :
Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6141 (Electronic) NLM ISO Abbreviation: Biomed Res Int Subsets: MEDLINE
MeSH Terms :
Prognosis*
Gastrointestinal Tract/*metabolism
MicroRNAs/*genetics
Neoplasms/*genetics
Computational Biology ; Gastrointestinal Tract/pathology ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic ; Gene Regulatory Networks/genetics ; High-Throughput Nucleotide Sequencing ; Humans ; Kaplan-Meier Estimate ; MicroRNAs/classification ; Molecular Sequence Annotation ; Neoplasms/diagnosis ; Neoplasms/pathology ; RNA, Messenger/genetics ; Signal Transduction/genetics
Czasopismo naukowe
Tytuł :
SCORE risk scale as a prognostic factor after sudden sensorineural hearing loss.
Autorzy :
Menezes AS; Department Of Otorhinolaryngology-Head and Neck Surgery, Hospital De Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal. .
Ribeiro D; Department Of Otorhinolaryngology-Head and Neck Surgery, Hospital De Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal.
Lima A; Department Of Otorhinolaryngology-Head and Neck Surgery, Hospital De Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal.
Miranda D; Department Of Otorhinolaryngology-Head and Neck Surgery, Hospital De Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal.
Guimarães J; Department of Otorhinolaryngology, Instituto Português de Oncologia Francisco Gentil Do Porto, Porto, Portugal.
Dias L; Department Of Otorhinolaryngology-Head and Neck Surgery, Hospital De Braga, Sete Fontes, São Victor, 4710-243, Braga, Portugal.
Pokaż więcej
Źródło :
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2019 Oct; Vol. 276 (10), pp. 2739-2745. Date of Electronic Publication: 2019 Jun 20.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Springer International Country of Publication: Germany NLM ID: 9002937 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-4726 (Electronic) Linking ISSN: 09374477 NLM ISO Abbreviation: Eur Arch Otorhinolaryngol Subsets: MEDLINE
MeSH Terms :
Prognosis*
Risk Assessment*
Hearing Loss, Sensorineural/*epidemiology
Hearing Loss, Sudden/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Audiometry, Pure-Tone ; Cardiovascular Diseases/epidemiology ; Dexamethasone/therapeutic use ; Diabetes Mellitus/epidemiology ; Female ; Glucocorticoids/therapeutic use ; Hearing Loss, Sensorineural/drug therapy ; Hearing Loss, Sudden/drug therapy ; Humans ; Injection, Intratympanic ; Male ; Middle Aged ; Obesity/epidemiology ; Prospective Studies ; Recovery of Function ; Smoking/epidemiology ; Stroke/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Deep learning-based classification of mesothelioma improves prediction of patient outcome.
Autorzy :
Courtiol P; Owkin Lab, Owkin, Inc., New York, NY, USA.
Maussion C; Owkin Lab, Owkin, Inc., New York, NY, USA.
Moarii M; Owkin Lab, Owkin, Inc., New York, NY, USA.
Pronier E; Owkin Lab, Owkin, Inc., New York, NY, USA.
Pilcer S; Owkin Lab, Owkin, Inc., New York, NY, USA.
Sefta M; Owkin Lab, Owkin, Inc., New York, NY, USA.
Manceron P; Owkin Lab, Owkin, Inc., New York, NY, USA.
Toldo S; Owkin Lab, Owkin, Inc., New York, NY, USA.
Zaslavskiy M; Owkin Lab, Owkin, Inc., New York, NY, USA.
Le Stang N; Department of Biopathology, MESOPATH/MESOBANK Cancer Center Léon Bérard, Lyon, France.
Girard N; Université de Lyon, Université Claud Bernard Lyon 1, Lyon, France.; Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.
Elemento O; Department of Physiology and Biophysics, Institute for Computational Biomedicine and Caryl and Israel Englander Institute for Precision Medicine, WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, NY, USA.
Nicholson AG; Department of Histopathology, Royal Brompton and Harefield Hospitals NHS Foundation Trust, and National Heart and Lung Institute, Imperial College, London, UK.
Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Galateau-Sallé F; Department of Biopathology, MESOPATH/MESOBANK Cancer Center Léon Bérard, Lyon, France.
Wainrib G; Owkin Lab, Owkin, Inc., New York, NY, USA.
Clozel T; Owkin Lab, Owkin, Inc., New York, NY, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2019 Oct; Vol. 25 (10), pp. 1519-1525. Date of Electronic Publication: 2019 Oct 07.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat. Med. Subsets: MEDLINE
MeSH Terms :
Prognosis*
Lung Neoplasms/*diagnosis
Lung Neoplasms/*pathology
Mesothelioma/*diagnosis
Mesothelioma/*pathology
Deep Learning ; Female ; Humans ; Lung Neoplasms/classification ; Male ; Mesothelioma/classification ; Neoplasm Grading ; Neural Networks, Computer
SCR Disease Name :
Mesothelioma, Malignant
Czasopismo naukowe
Tytuł :
A clonal expression biomarker associates with lung cancer mortality.
Autorzy :
Biswas D; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O'Gorman Building, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK. .; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. .; Department of Molecular Medicine, Aarhus University, Aarhus, Denmark. .; Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark. .
Rosenthal R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O'Gorman Building, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Lim EL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Papp K; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
Boeing S; Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK.
Krzystanek M; Danish Cancer Society Research Center, Copenhagen, Denmark.
Djureinovic D; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
La Fleur L; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Greco M; Genomics Equipment Park, The Francis Crick Institute, London, UK.
Döme B; Department of Tumor Biology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary.; Division of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Thoracic Surgery, National Institute of Oncology, Semmelweis University, Budapest, Hungary.
Fillinger J; Department of Pathology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary.; Department of Pathology, National Institute of Oncology, Budapest, Hungary.
Brunnström H; Lund University, Laboratory Medicine Region Skåne, Department of Clinical Sciences Lund, Pathology, Lund, Sweden.
Wu Y; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Moore DA; Department of Pathology, UCL Cancer Institute, London, UK.
Skrzypski M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.; Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Wilson GA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
Moldvay J; Department of Tumor Biology, National Korányi Institute of Pulmonology, Semmelweis University, Budapest, Hungary.; SE-NAP Brain Metastasis Research Group, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.
Botling J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Chinnaiyan AM; Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI, USA.; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.; Department of Urology, University of Michigan, Ann Arbor, MI, USA.; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI, USA.
Micke P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Hackshaw A; Cancer Research UK & University College London Cancer Trials Centre, University College London, London, UK.
Bartek J; Danish Cancer Society Research Center, Copenhagen, Denmark.; Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden.
Csabai I; Department of Physics of Complex Systems, ELTE Eötvös Loránd University, Budapest, Hungary.
Szallasi Z; Danish Cancer Society Research Center, Copenhagen, Denmark.; SE-NAP Brain Metastasis Research Group, 2nd Department of Pathology, Semmelweis University, Budapest, Hungary.; Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, Paul O'Gorman Building, London, UK.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK. .; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK. .
Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, London, UK. .; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. .
Pokaż więcej
Corporate Authors :
TRACERx Consortium
Źródło :
Nature medicine [Nat Med] 2019 Oct; Vol. 25 (10), pp. 1540-1548. Date of Electronic Publication: 2019 Oct 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat. Med. Subsets: MEDLINE
MeSH Terms :
Prognosis*
Clonal Evolution/*genetics
Lung Neoplasms/*genetics
Transcriptome/*genetics
Aged ; Biomarkers, Tumor/genetics ; DNA Copy Number Variations/genetics ; Disease-Free Survival ; Exome/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Heterogeneity ; Humans ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Male ; Risk Factors ; Whole Exome Sequencing
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies